image
CytomX Therapeutics, Inc. CTMX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.91
-9 %
$ 71.2 M
Market Cap
6.07
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 90.38% 99.42% 93.60%
Annual Report FY 10-K 2022-12-31 -23.59% -20.65% -20.95%
Annual Report FY 10-K 2021-12-31 -30.68% -145.24% -72.37%
Annual Report FY 10-K 2020-12-31 74.58% 67.83% 56.17%
Annual Report FY 10-K 2019-12-31 -3.38% -20.84% -42.40%
Annual Report FY 10-K 2018-12-31 -16.92% -96.30% -68.34%
Annual Report FY 10-K 2017-12-31 376.12% 26.83% 22.37%
Annual Report FY 10-K 2016-12-31 95.06% -66.51% -79.46%
Annual Report FY 10-K 2015-12-31 51.90% -16.71% -11.55%
Annual Report FY 10-K 2014-12-31 471.73% -100.16% -99.02%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 26.71% 91.71% 31.64%
Quarterly Report Q2 8-K 2024-06-30 1.58% -501.10% -152.45%
Quarterly Report Q1 8-K 2024-03-31 76.45% 1523.22% 306.21%
Quarterly Report Q4 8-K 2023-12-31 2712.58% 103.15% 97.89%
Quarterly Report Q3 8-K 2023-09-30 55.98% 113.21% 113.04%
Quarterly Report Q2 8-K 2023-06-30 36.11% 95.40% 86.47%
Quarterly Report Q1 8-K 2023-03-31 37.13% 95.93% 76.41%
Quarterly Report Q4 8-K 2022-12-31 -95.20% -1.34% -9.04%
Quarterly Report Q3 8-K 2022-09-30 -3.82% -0.29% -5.75%
Quarterly Report Q2 8-K 2022-06-30 11.52% -22.78% -28.83%
Quarterly Report Q1 8-K 2022-03-31 7.29% -53.04% -53.36%
Quarterly Report Q4 8-K 2021-12-31 20.48% -78.41% -78.01%
Quarterly Report Q3 8-K 2021-09-30 -1.13% -53.53% -52.00%
Quarterly Report Q2 8-K 2021-06-30 -1.93% -22.73% -19.00%
Quarterly Report Q1 8-K 2021-03-31 -67.80% -127.44% -459.51%
Quarterly Report Q4 8-K 2020-12-31 97.77% 58.54% 60.46%
Quarterly Report Q3 8-K 2020-09-30 66.06% 37.93% 42.08%
Quarterly Report Q2 8-K 2020-06-30 84.27% 45.86% 48.33%
Quarterly Report Q1 8-K 2020-03-31 68.20% 186.41% 83.14%
Quarterly Report Q4 8-K 2019-12-31 -27.83% -10.00% -44.82%
Quarterly Report Q3 8-K 2019-09-30 -14.37% -1.14% -10.96%
Quarterly Report Q2 8-K 2019-06-30 -57.76% -115.36% -135.60%
Quarterly Report Q1 8-K 2019-03-31 107.88% 8.84% -5.98%
Quarterly Report Q4 8-K 2018-12-31 -57.63% -5190.50% -1969.77%
Quarterly Report Q3 8-K 2018-09-30 -48.19% -128.66% -110.22%
Quarterly Report Q2 8-K 2018-06-30 143.81% 46.67% 47.75%
Quarterly Report Q1 8-K 2018-03-31 21.72% -87.63% -81.45%
Quarterly Report Q4 8-K 2017-12-31 331.65% 104.43% 91.24%
Quarterly Report Q3 8-K 2017-09-30 599.02% 30.11% 26.09%
Quarterly Report Q2 8-K 2017-06-30 182.87% -77.88% -77.96%
Quarterly Report Q1 8-K 2017-03-31 424.20% 48.49% 46.77%
Quarterly Report Q4 8-K 2016-12-31 215.49% -22.16% -23.48%
Quarterly Report Q3 8-K 2016-09-30 78.13% -23.52% -32.36%
Quarterly Report Q2 8-K 2016-06-30 51.44% -144.16% -157.27%
Quarterly Report Q1 8-K 2016-03-31 27.61% -158.07% -232.42%
Quarterly Report Q4 8-K 2015-12-31 6.82% -139.96% -147.35%
Quarterly Report Q3 8-K 2015-09-30 1.25% -230.73% -225.32%
Quarterly Report Q2 8-K 2015-06-30 206.76% 4.51% -15.58%
Quarterly Report Q1 8-K 2015-03-31 174.33% 65.60% 71.10%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%